Evidence map›Paper›PMID 28426732›Full record

ArticlePloS one2017

Regulation of SESAME-mediated H3T11 phosphorylation by glycolytic enzymes and metabolites.

Qi Yu, Chong Tong, Mingdan Luo, Xiangyan Xue, Qianyun Mei, Lixin Ma, Xiaolan Yu, Wuxiang Mao, Lingbao Kong, Xilan Yu and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer.Frontiers in cell and developmental biology · 2021
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Qi YuHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Chong TongHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Mingdan LuoHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Xiangyan XueHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Qianyun MeiHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Lixin MaHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Xiaolan YuHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Wuxiang MaoHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Lingbao KongDepartment of HumanPopulation Genetics, Human Aging Research Institute and School of Life Science, Nanchang University, Nanchang, China.
Xilan YuHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Shanshan LiHubei Collaborative Innovation Center for Green Transformation of Bio-resources,College of Life Sciences, Hubei University, Wuhan, Hubei, China.
Hubei University · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cells prefer aerobic glycolysis, but little is known about the underlying mechanism. Recent studies showed that the rate-limiting glycolytic enzymes, pyruvate kinase M2 (PKM2) directly phosphorylates H3 at threonine 11 (H3T11) to regulate gene expression and cell proliferation, revealing its non-metabolic functions in connecting glycolysis and histone modifications. We have reported that the yeast homolog of PKM2, Pyk1 phosphorylates H3T11 to regulate gene expression and oxidative stress resistance. But how glycolysis regulates H3T11 phosphorylation remains unclear. Here, using a series of glycolytic enzyme mutants and commercial available metabolites, we investigated the role of glycolytic enzymes and metabolites on H3T11 phosphorylation. Mutation of glycolytic genes including phosphoglucose isomerase (PGI1), enolase (ENO2), triosephosphate isomerase (TPI1), or folate biosynthesis enzyme (FOL3) significantly reduced H3T11 phosphorylation. Further study demonstrated that glycolysis regulates H3T11 phosphorylation by fueling the substrate, phosphoenonylpyruvate and the coactivator, FBP to Pyk1. Thus, our results provide a comprehensive view of how glycolysis modulates H3T11 phosphorylation.

Indexed as

Folic AcidGene Expression Regulation, FungalGlycolysisHistonesHumansPhosphopyruvate HydratasePhosphorylationPyruvate KinaseFolic AcidHistonesPhosphopyruvate HydratasePyruvate Kinase

Identifiers

PMID28426732
PMCPMC5398556
OpenAlexW2607090380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.